Biotech Distilled
133 companies · 839 active programs
Substack ↗
Subscribe
Therapeutic Areas
Modalities
Phases
Targets
Companies
Home
›
Targets
› RYR2
RYR2
(1 companies · 1 programs)
Companies with an active program directed at RYR2.
Solid Biosciences Inc.
SLDB
SGT-501
— Catecholaminergic Polymorphic Ventricular Tachycardia
Phase 1